Abstract
The Therapeutic Goods Act 1989 (Cth) constitutes an important segment of the consumer law regulatory regime applying to complementary and alternative medicine (‘CAM’). This article critically evaluates that regime, concentrating on the level of evidence required to justify health claims for registration or listing of CAM products and in relation to the advertising of such products. It identifies the anomalies that arise from the application of the current regulatory structure, and offers conclusions and recommendations intended to improve the present position
| Original language | English |
|---|---|
| Pages (from-to) | 13-34 |
| Number of pages | 22 |
| Journal | Bond Law Review |
| Volume | 25 |
| Issue number | 1 |
| Publication status | Published - 2013 |